2023/2157(DEC) 2022 discharge: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Lead committee dossier:
Progress: Procedure completed, awaiting publication in Official Journal
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | CONT | SARVAMAA Petri ( EPP) | RÓNAI Sándor ( S&D), STRUGARIU Ramona ( Renew), EICKHOUT Bas ( Verts/ALE), KUHS Joachim ( ID), CZARNECKI Ryszard ( ECR), OMARJEE Younous ( GUE/NGL) |
Committee Opinion | ENVI | ||
Committee Opinion | LIBE | ZDECHOVSKÝ Tomáš ( EPP) | Konstantinos ARVANITIS ( GUE/NGL), Saskia BRICMONT ( Verts/ALE), Assita KANKO ( ECR), Ramona STRUGARIU ( RE), Nils UŠAKOVS ( S&D) |
Lead committee dossier:
Subjects
Events
2024/04/11
EP - Text adopted by Parliament, single reading
Documents
2024/04/11
EP - Decision by Parliament
Documents
2024/04/10
EP - Debate in Parliament
Documents
2024/03/12
CSL - Supplementary non-legislative basic document
Documents
2024/03/12
EP - Committee report tabled for plenary, single reading
Documents
2024/03/12
EP - Committee report tabled for plenary
Documents
2024/03/04
EP - Vote in committee
2024/02/12
EP - Amendments tabled in committee
Documents
2024/01/25
EP - Committee opinion
Documents
2024/01/09
EP - Committee draft report
Documents
2023/11/13
EP - ZDECHOVSKÝ Tomáš (EPP) appointed as rapporteur in LIBE
2023/10/26
CofA - Court of Auditors: opinion, report
Documents
2023/09/12
EP - Committee referral announced in Parliament
2023/06/28
EC - Non-legislative basic document
Documents
2023/06/28
EC - Non-legislative basic document published
Documents
2023/06/14
EP - SARVAMAA Petri (EPP) appointed as rapporteur in CONT
Documents
- Text adopted by Parliament, single reading: T9-0241/2024
- Decision by Parliament: T9-0241/2024
- Debate in Parliament: Debate in Parliament
- Supplementary non-legislative basic document: 06180/2024
- Committee report tabled for plenary, single reading: A9-0104/2024
- Committee report tabled for plenary: A9-0104/2024
- Amendments tabled in committee: PE757.227
- Committee opinion: PE756.194
- Committee draft report: PE753.525
- Court of Auditors: opinion, report: OJ C 000 27.10.2023, p. 0000
- Court of Auditors: opinion, report: N9-0096/2023
- Non-legislative basic document: COM(2023)0391
- Non-legislative basic document: EUR-Lex
- Non-legislative basic document published: COM(2023)0391
- Non-legislative basic document published: EUR-Lex
- Non-legislative basic document: COM(2023)0391 EUR-Lex
- Court of Auditors: opinion, report: OJ C 000 27.10.2023, p. 0000 N9-0096/2023
- Committee draft report: PE753.525
- Committee opinion: PE756.194
- Amendments tabled in committee: PE757.227
- Supplementary non-legislative basic document: 06180/2024
- Committee report tabled for plenary, single reading: A9-0104/2024
- Text adopted by Parliament, single reading: T9-0241/2024
Votes
A9-0104/2024 – Petri Sarvamaa – Motion for a resolution #
2024/04/11 Outcome: +: 534, -: 46, 0: 22
Amendments | Dossier |
12 |
2023/2157(DEC)
2023/12/05
LIBE
9 amendments...
Amendment 1 #
Draft opinion Paragraph 1 1. Welcomes the fact that the Court of Auditors (the ‘Court’) has declared the transactions underlying the annual accounts of the European Monitoring Centre for Drugs and Drug Addiction (the 'Centre’) for the financial year 2022 to be legal and regular in all material respects; notes that, according to the Court’s Annual Report on EU agencies for the year 2022, its budget in 2022 amounted to EUR 26 million, an increase of 4% compared to 2021 (EUR 25 million), while its staff number remained unchanged;
Amendment 2 #
Draft opinion Paragraph 1 a (new) 1 a. Welcomes that appropriated corrective actions were taken to address the Court’s previous years observation;
Amendment 3 #
Draft opinion Paragraph 2 2. Welcomes the yearly flagship publication, the European Drug Report 2022, the Statistical Bulletin 2022 and the added value of the EU Early Warning System on new psychoactive substances run by the Centre for 25 years in 2022; welcomes the release of 69 publications, among which seven miniguides and three spotlights under the Centre’s flagship report “Health and social responses to drug problems: a European guide”; welcomes the organization of the fourth European Conference on Addictive Behaviours and Dependencies jointly organized by the Centre and its partners; encourages the Centre to continue in its knowledge sharing activities;
Amendment 4 #
Draft opinion Paragraph 2 2. Welcomes the yearly flagship publication, the European Drug Report 2022, the Statistical Bulletin 2022 and the added value of the EU Early Warning System on new psychoactive substances run by the Centre for 25 years in 2022; welcomes the release of seven miniguides and three spotlights under the Centre’s flagship report Health and social responses to drug problems: a European guide; welcomes the organization of the fourth European Conference on Addictive Behaviours and Dependencies jointly organized by the Centre and its partners; encourages the Centre to continue in its knowledge sharing activities;
Amendment 5 #
Draft opinion Paragraph 3 3. Welcomes the drug-related training activities with participation of 609 law enforcement professionals from the EU and technical cooperation project partners delivered by the Centre in cooperation with the European Union Agency for Law Enforcement Training (CEPOL); welcomes that almost 950 professionals working in the drugs field, including law enforcement officers and policymakers, received Centre training during 2022, while around 1 200 professionals working in the drugs field attended the seven webinars organized by Centre; considers it essential to continue raising awareness of the importance of prevention and innovative mental-health-based approach to drugs policies;
Amendment 6 #
Draft opinion Paragraph 3 3. Welcomes the drug-related training activities with participation of 609 law enforcement professionals from the EU and technical cooperation project partners delivered by the Centre in cooperation with the European Union Agency for Law Enforcement Training (CEPOL); welcomes that in 2022 almost 950 professionals working in the drugs field, including law enforcement officers and policymakers were trained and around 1 200 professionals working in the drugs field attended the seven webinars organized by the Centre; considers
Amendment 7 #
Draft opinion Paragraph 3 3. Welcomes the drug-related training activities with participation of 609 law enforcement professionals from the EU and technical cooperation project partners delivered by the Centre in cooperation with the European Union Agency for Law Enforcement Training (CEPOL); considers it essential to continue raising awareness of the importance of prevention and innovative mental-health-based approach to drugs policies; highlights the important role of the Centre in providing policy- makers and practitioners with public- health-based analyses and information concerning drugs and drug addiction;
Amendment 8 #
Draft opinion Paragraph 4 4. Welcomes the progress made by the Centre on the joint EU Drug Markets: In- depth analysis, in collaboration with Europol, with modules on specific drugs released throughout 2022 and with planned releases in 2023; welcomes the work in 2022 on improving the quality and availability of core supply data in collaboration with the Reitox National Focus Points and Europol; welcomes the implementation of all of the Centre’s tasks under the Multidisciplinary Platform Against Criminal Threats operational action plans on cannabis, cocaine and heroin; recalls that drug trafficking has been identified as a main source of profit and a channel of recruitment of organized crime and terrorism, and highlights the contribution of the Centre to a more secure Europe; recalls that the Center’s work is based on two pillars, the security-related strategic objectives and the health-related strategic objectives, the latter should not be overshadowed by the first;
Amendment 9 #
Draft opinion Paragraph 4 a (new) 4 a. Welcomes the Centre’s unremitting efforts to highlight the social aspects and societal impact of drugs, promote social re-integration policies for drug users, and approach the topic of drugs with a multi-disciplinary outlook.
source: 756.999
2024/02/12
CONT
3 amendments...
Amendment 1 #
Motion for a resolution Paragraph 2 2. Notes from the Court’s report that the Centre, although it paid interest for only one late payment, had a significant number of payments wrongly flagged as late (107 out of 1 595) by the Centre’s financial and accounting management (ABAC) because of the incorrect parametrisations and/or incorrect data inputs regarding the due date of payment or the reception of the documents entailing a payment obligation; notes from the Centre’s reply that the inconsistent flagging of late payments did not affect the regularity of the operations involved; notes further that the Centre has adopted some measures to minimize the referred risk for ‘false positive’ and to further ensure that its ABAC system may provide for a clear and accurate picture of the actual late payments; calls on the Agency to continue to monitor this issue and mitigate possible future reputational risks associated to this issue;
Amendment 2 #
Motion for a resolution Paragraph 6 6. Notes with appreciation that in 2022 the Centre released a new rapid mixed-method trendspotter study to assess the initial service response to the needs of displaced Ukrainians in neighbouring countries within the Union; commends the Centre for collaborating with Europol for preparing the fourth edition of the joint EU Drug Markets: In-depth analysis, the findings of which are presented in a series of modules, each focusing on the market for a particular drug and covering trends along the supply chain from production and trafficking to distribution and use; commends in this context the launch in 2022 of the first two modules on cocaine and methamphetamine;
Amendment 3 #
Motion for a resolution Paragraph 13 13. Notes that the Centre reported to have 2 women (22%) and 7 men (78%) in its senior management, while it has 20 women (37%) and 34 men (63%) in its management board (MB); notes that the staff overall is composed of 36 men (38 %) and 58 women (62%); recalls the importance to ensure staff gender balance and calls on the Centre to take this aspect into consideration with regard to future recruitments of staff
source: 757.227
|
History
(these mark the time of scraping, not the official date of the change)
2024-04-17Show (5) Changes | Timetravel
docs/7 |
|
events/4 |
|
events/5 |
|
forecasts |
|
procedure/stage_reached |
Old
Awaiting Parliament's voteNew
Procedure completed, awaiting publication in Official Journal |
2024-04-16Show (5) Changes | Timetravel
docs/7 |
|
events/4 |
|
events/5 |
|
forecasts |
|
procedure/stage_reached |
Old
Awaiting Parliament's voteNew
Procedure completed, awaiting publication in Official Journal |
2024-04-15Show (2) Changes | Timetravel
events/4 |
|
forecasts |
|
2024-04-13Show (2) Changes | Timetravel
events/4 |
|
forecasts |
|
2024-04-12Show (3) Changes | Timetravel
events/4 |
|
forecasts/0 |
|
forecasts/0 |
|
2024-03-27Show (2) Changes | Timetravel
docs/6 |
|
events/3/docs |
|
2024-03-26Show (2) Changes | Timetravel
docs/6 |
|
events/3/docs |
|
2024-03-15Show (3) Changes | Timetravel
docs/5 |
|
events/3 |
|
procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Parliament's vote |
2024-03-14Show (2) Changes | Timetravel
events/3 |
|
procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Parliament's vote |
2024-03-13Show (2) Changes | Timetravel
events/3 |
|
procedure/stage_reached |
Old
Awaiting committee decisionNew
Awaiting Parliament's vote |
2024-03-06Show (2) Changes | Timetravel
events/2 |
|
procedure/Other legal basis |
Rules of Procedure EP 159
|
2024-02-29Show (1) Changes | Timetravel
forecasts |
|
2024-02-13Show (1) Changes | Timetravel
docs/4 |
|
2024-01-26Show (1) Changes | Timetravel
docs/3 |
|
2024-01-24Show (1) Changes | Timetravel
docs/2 |
|
2023-12-09Show (1) Changes | Timetravel
docs/1 |
|
2023-11-17Show (1) Changes | Timetravel
committees/2/rapporteur |
|
2023-11-09Show (1) Changes | Timetravel
commission |
|
2023-09-15Show (3) Changes | Timetravel
events/1 |
|
procedure/dossier_of_the_committee |
|
procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting committee decision |
2023-09-13Show (3) Changes | Timetravel
committees/1 |
|
committees/1/opinion |
False
|
committees/2 |
|
2023-09-01Show (3) Changes | Timetravel
committees/0/shadows/4 |
|
committees/1 |
Old
New
|
committees/2 |
Old
New
|
2023-07-28Show (2) Changes
committees/0 |
|
committees/0 |
|